Registry of patients treated with transcatheter aortic valve implantation
A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg
Segeberger Kliniken GmbH · NCT03192774
This study is tracking the health and recovery of patients who receive a new heart valve through a minimally invasive procedure to see how well it works over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Segeberger Kliniken GmbH (other) |
| Locations | 1 site (Bad Segeberg) |
| Trial ID | NCT03192774 on ClinicalTrials.gov |
What this trial studies
This registry collects data from all patients who undergo transcatheter aortic valve implantation (TAVI) at the Heart Center in Bad Segeberg, Germany. It aims to monitor patient outcomes through routine clinical and echocardiographic follow-ups, extending beyond five years to evaluate the durability of the implanted valves. The study is observational, meaning it will gather data without altering the standard treatment protocols for these patients.
Who should consider this trial
Good fit: Ideal candidates for this registry are all patients who are treated with TAVI at the Heart Center.
Not a fit: Patients who do not undergo TAVI or are treated at other facilities may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of TAVI, ultimately improving patient care.
How similar studies have performed: Other registries and studies on TAVI have shown success in improving patient outcomes and understanding valve durability, indicating that this approach is supported by previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None
Where this trial is running
Bad Segeberg
- Heart Center, Segeberger Kliniken — Bad Segeberg, Germany (RECRUITING)
Study contacts
- Principal investigator: Mohamed Abdel-Wahab, MD — Heart Center, Segeberger Kliniken
- Study coordinator: Mohamed Abdel-Wahab, MD
- Email: msabdelwahab@gmail.com
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Aortic Valve Stenosis